Corpus Intelligence IC Memo — SSH - QUAD CITIES INC. 2026-04-26 12:34 UTC
IC Memo — SSH - QUAD CITIES INC.
Investment Committee Memorandum | IA | 50 beds | Grade D | EBITDA uplift $1.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - QUAD CITIES INC.

CCN 162001 | SCOTT, IA | 50 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH - QUAD CITIES INC. is a 50-bed community hospital in SCOTT, IA with $14.1M in net patient revenue and a -14.4% operating margin. The hospital serves a payer mix of 66.6% Medicare, 0.0% Medicaid, and 33.4% commercial.

Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -14.4% to -7.0% (+737bps).

Net Revenue HCRIS$14.1M
Current EBITDA COMPUTED$-2.0M
Operating Margin COMPUTED-14.4%
Occupancy HCRIS38.9%
Revenue / Bed COMPUTED$283K
Net-to-Gross HCRIS19.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

124
IA Hospitals
-8.2%
State Median Margin
76
Comparable Hospitals

IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of -14.4% places it below the state median. Among 76 size-comparable peers (25-100 beds), the median margin is -7.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 76 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - QUAD CITIES INC. (Target)IA50$14.1M-14.4%
TRINITY REGIONAL MEDICAL CENTEIA44$140.4M-6.8%
THE FINLEY HOSPITALIA66$121.7M0.1%
PELLA REGIONAL HEALTH CENTERIA25$108.8M-16.6%
SPENCER MUNICIPAL HOSPITALIA49$108.7M-10.3%
TRINITY BETTENDORFIA81$90.6M-3.7%
GREATER REGIONAL MEDICAL CENTEIA25$89.4M-4.4%
ST. ANTHONY REGIONAL HOSPITALIA49$84.0M-21.0%
WINNESHIEK MEDICAL CENTERIA25$77.6M-0.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$297K+210bp18mo
Cost to Collect4.5%2.5%$283K+200bp12mo
Denial Rate Reduction12.0%6.5%$280K+198bp12mo
A/R Days Reduction5200.0%3800.0%$172K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$297K
Cost to Collect
$283K
Denial Rate Reduction
$280K
A/R Days Reduction
$172K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.0M
Current EBITDA$-2.0M
+ RCM Uplift+$1.0M
Pro Forma EBITDA$-990K
Current Margin-14.4%
Pro Forma Margin-7.0%
WC Released (1x)$542K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.1M$-3.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.1M$-4.3M0.00x-100.0%
Bull Case9.0x11.0x$-2.8M$-1.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.8M$-2.9M0.00x-100.0%
Bear Case11.0x10.0x$-3.4M$-7.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.4M$-9.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 66.6% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 76 hospitals with 25-100 beds
  • Same-state prioritization (n=77)
  • Comp margins: P25=-13.6% / P50=-7.2% / P75=-3.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.